Pulse Biosciences (PLSE) Stock Statistics & Valuation Metrics

Pulse Biosciences has a market cap or net worth of $1.82B. The enterprise value is $1.70B.

Pulse Biosciences has 69,209,710 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pulse Biosciences’s return on equity (ROE) is -0.90 and return on invested capital (ROIC) is -85.72%.

The current PE Ratio of Pulse Biosciences is ―. Pulse Biosciences’s PEG ratio is -0.73.

In the last 12 months, Pulse Biosciences had revenue of 350.00K and earned -72.78M in profits. Earnings per share was -1.08.

In the last 12 months, operating cash flow was -55.20M and capital expenditures -303.00K, giving a free cash flow of -55.50M billion.

Pulse Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Pulse Biosciences upcoming earnings date is Aug 12, 2026, TBA (Not Confirmed).

Pulse Biosciences as a current ratio of 10.53, with Debt / Equity ratio of 10.79%

In the past 12 months, Pulse Biosciences has paid 0.00 in taxes.

Pulse Biosciences EV to EBITDA ratio is -11.88, with an EV/FCF ratio of -15.65.

Pulse Biosciences has $68.32M in cash and marketable securities with $7.16M in debt, giving a net cash position of $61.16M billion.

Gross margin is -91.08%, with operating margin of -21982.57%, and net profit margin of -20794.57%.

The average price target for Pulse Biosciences is $31.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy